Mizuguchi Yukio, Ishimoto Takeo, Kageyama Norihito, Oishi Yoshifumi, Emi Shigefumi, Nagase Norio, Oki Takashi
Cardiovascular Section, Higashi Tokushima National Hospital, National Hospital Organization, 1-1 Ohmukai-Kita, Ohtera, Itano, Tokushima 779-0193, Japan.
Cardiovasc Drugs Ther. 2004 Sep;18(5):405-8. doi: 10.1007/s10557-005-5066-8.
A 67-year-old man with neurally mediated syncope (NMS) complicated by prostatic hypertrophy responded well to combined therapy with pirmenol and midodrine. In 2003, syncope occurred while the patient was driving a car. Results of head-up tilt-table testing (HUT) suggested a mixed type of NMS. Oral administration of disopyramide provided severe urinary obstruction. Pirmenol treatment was not associated with syncope during ordinary HUT, but nausea, sweating, and syncope occurred during HUT with provocative administration of isosorbide dinitrate. Combined therapy with pirmenol and midodrine avoided syncope during HUT, and has prevented attacks since discharge from the hospital.